# Detection of Chlamydia (CT) and Gonorrhea (NG)

> **NCT02055742** · — · COMPLETED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 700 (estimated)

## Conditions studied

- Chlamydia
- Gonorrhea

## Interventions

- **DEVICE:** illumigene CT and NG assays, illumipro-10

## Key facts

- **NCT ID:** NCT02055742
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-01
- **Primary completion:** 2014-09-09
- **Final completion:** 2014-09-09
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055742, "Detection of Chlamydia (CT) and Gonorrhea (NG)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02055742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*